跳至主要内容
临床试验/CTRI/2025/10/096032
CTRI/2025/10/096032尚未招募不适用

Prescription pattern and safety of ketamine-midazolam combination in adult burn patients

Manipal Academy Of Higher Education1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年11月11日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1
主要终点
Assesment of change in pain scores at random time points

研究概览

简要总结

This study will prospectively evaluate how ketamine–midazolam combination is prescribed and how safe it is in adult burn patients during painful procedures. Patients will receive the drug combination intravenously, and their pain, sedation levels, and side effects will be closely monitored. The findings aim to strengthen pain management strategies and improve overall patient care during treatment of burns.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Adult patients above or equal to 18 years with burn injuries.

排除标准

  • Patients Not willing to participate in the study.

结局指标

主要结局

Assesment of change in pain scores at random time points

时间窗: random points from time of administration to half life ( ketamine half life 2-4 hours, Midazolam half life 1.5-2.5 hours)

次要结局

  • • Assessment of sedation level(• Requirement for rescue medication)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Shreeya U Shetty

Manipal College Of Pharmaceutical Sciences

研究点 (1)

Loading locations...

相似试验